Next, we separated the patients into different groups according to the expression of the proteins of P16INK4A and stem cell markers SOX2 and ALDH1A1 of the tumor samples obtained before radiotherapy and examined the association among these protein expressions with the five-year overall survival (OS) and disease-free survival (DFS) pattern of the patients. The gene discussed is CDKN2A; the disease is neoplasm.